Literature DB >> 19499194

[53 year-old patient with fever and cough].

C Orasch1, M Battegay.   

Abstract

We describe a patient with late HIV presentation, opportunistic infections and an immune reconstitution syndrome (IRIS) after starting a combination antiretroviral therapy (ART)occurring in this severely immunodeficient patient. In the beginning, a miliary tuberculosis was diagnoses, followed by a second opportunistic infection, i.e. pneumocystis jiroveci pneumonia. After start of ART, further organ manifestations developed, interpreted as immune reconstitution syndrome. The decision about the optimal time point for starting ART in the presence of an opportunistic infection is essential.

Entities:  

Mesh:

Year:  2009        PMID: 19499194     DOI: 10.1007/s00108-009-2340-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  11 in total

Review 1.  Immunological recovery and antiretroviral therapy in HIV-1 infection.

Authors:  Manuel Battegay; Reto Nüesch; Bernard Hirschel; Gilbert R Kaufmann
Journal:  Lancet Infect Dis       Date:  2006-05       Impact factor: 25.071

2.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2007-01-30       Impact factor: 4.177

Review 3.  Clinical indicators of immune restoration following highly active antiretroviral therapy.

Authors:  Elizabeth L Cooney
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

4.  Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

Authors:  M A French; N Lenzo; M John; S A Mallal; E J McKinnon; I R James; P Price; J P Flexman; M L Tay-Kearney
Journal:  HIV Med       Date:  2000-03       Impact factor: 3.180

Review 5.  Immunorestitution disease involving the innate and adaptive response.

Authors:  V C Cheng; K Y Yuen; W M Chan; S S Wong; E S Ma; R M Chan
Journal:  Clin Infect Dis       Date:  2000-06-20       Impact factor: 9.079

6.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

Review 7.  Late presentation of HIV-infected individuals.

Authors:  Manuel Battegay; Ursula Fluckiger; Bernard Hirschel; Hansjakob Furrer
Journal:  Antivir Ther       Date:  2007

8.  Immune reconstitution in HIV-infected patients.

Authors:  Hans H Hirsch; Gilbert Kaufmann; Pedram Sendi; Manuel Battegay
Journal:  Clin Infect Dis       Date:  2004-04-05       Impact factor: 9.079

9.  Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

Authors:  I Ratnam; C Chiu; N-B Kandala; P J Easterbrook
Journal:  Clin Infect Dis       Date:  2005-12-28       Impact factor: 9.079

10.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

View more
  1 in total

1.  Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentation.

Authors:  S Sovaila; A de Raigniac; C Picard; O Taulera; C Lascoux-Combe; D Sereni; A Bourgarit
Journal:  J Med Life       Date:  2012-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.